Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014

N. Turner, N. Pierse, Q. S. Huang, S. Radke, A. Bissielo, M. G. Thompson, H. Kelly, on behalf of the SHIVERS investigation team

Research output: Contribution to journalArticleResearchpeer-review

20 Citations (Scopus)

Abstract

We present preliminary results of influenza vaccine effectiveness (VE) in New Zealand using a case test- negative design for 28 April to 31 August 2014. VE adjusted for age and time of admission among all ages against severe acute respiratory illness hospital presentation due to laboratory-confirmed influenza was 54% (95% CI: 19 to 74) and specifically against A(H1N1) pdm09 was 65% (95% CI:33 to 81). For influenza-con- firmed primary care visits, VE was 67% (95% CI: 48 to 79) overall and 73% (95% CI: 50 to 85) against A(H1N1) pdm09.

Original languageEnglish
Number of pages6
JournalEurosurveillance
Volume19
Issue number42
Publication statusPublished - 23 Oct 2014

Cite this